Clinical Studies
Excellent Safety Profile
R. Moskowitz 醫學博士評論 “膠原蛋白肽有優良安全性，自中世紀已作食品，FDA認定為安全(GRAS)，可作長期使用”。
Moskowitz, R. Role of collagen hydrolysate in bone and joints. Semin Arth Rheum, 2000, 30:87-99
Clinical Efficacy proved by Harvard University
美國哈佛大學醫學院利用dGEMRIC磁共振成像檢測証明關節炎患者服用JointOK關捷健後幫助關節軟骨重生。
Osteoarthritis and Cartilage 19 (2011) 399-405
Protect joints and enhance mobility / performance
臨床研究証明食用關捷健JointOK可保持關節健康，減少關節惡化風險和運動產生負面的影響如疼痛。
Current Medical Research & Opinion, 2008, Vol. 24, No. 5 : Pages 1485-149
JointOK for Healthy Aging
The reduction of collagen, the body’s main structural protein, is one of the most visible signs of aging.
Collagen is particularly concentrated in skin, bones, tendons and cartilage, where it has a role in the integrity of joint-related connective tissue.
At Vitafoods Europe 2014, Dr. Steffen Oesser of the Collagen Research Institute, noted that collagen peptides are now included in Mexican guidelines for the treatment of osteoarthritis.
JointOK contains bioactive collagen peptides which can stimulate osteoblasts to enhance extracellular bone matrix production, which is the essential framework for calcium mineralization and the regeneration of joint cartilage.
Dr. Oesser showed that the effects of collagen last longer when ingested rather than applied topically. Therefore, JointOK can align collagen with bone and joint health as well as beauty from within.